180 related articles for article (PubMed ID: 8425767)
1. Inhibition of growth-factor-activated proliferation by anti-estrogens and effects on early gene expression of MCF-7 cells.
Wosikowski K; Küng W; Hasmann M; Löser R; Eppenberger U
Int J Cancer; 1993 Jan; 53(2):290-7. PubMed ID: 8425767
[TBL] [Abstract][Full Text] [Related]
2. Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis.
Philips A; Chalbos D; Rochefort H
J Biol Chem; 1993 Jul; 268(19):14103-8. PubMed ID: 8314777
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
4. C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells.
Venditti M; Iwasiow B; Orr FW; Shiu RP
Int J Cancer; 2002 May; 99(1):35-42. PubMed ID: 11948489
[TBL] [Abstract][Full Text] [Related]
5. c-fos, c-jun and c-myc expressions are not growth rate limiting for the human MCF-7 breast cancer cells.
Wosikowski K; Eppenberger U; Küng W; Nagamine Y; Mueller H
Biochem Biophys Res Commun; 1992 Nov; 188(3):1067-76. PubMed ID: 1445344
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of DNA synthesis and c-fos mRNA expression in primary rat hepatocytes by estrogens.
Lee CH; Edwards AM
Carcinogenesis; 2001 Sep; 22(9):1473-81. PubMed ID: 11532870
[TBL] [Abstract][Full Text] [Related]
7. Effect of growth factors on estrogen receptor mediated gene expression.
Hafner F; Holler E; von Angerer E
J Steroid Biochem Mol Biol; 1996 Jul; 58(4):385-93. PubMed ID: 8903422
[TBL] [Abstract][Full Text] [Related]
8. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H
Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314
[TBL] [Abstract][Full Text] [Related]
9. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
Gründker C; Völker P; Schulz KD; Emons G
Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
[TBL] [Abstract][Full Text] [Related]
10. Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells.
Wakeling AE; Newboult E; Peters SW
J Mol Endocrinol; 1989 May; 2(3):225-34. PubMed ID: 2665780
[TBL] [Abstract][Full Text] [Related]
11. Effects of tamoxifen and retinoic acid on cell growth and c-myc gene expression in human breast and cervical cancer cells.
Tsai LC; Hung MW; Yuan CC; Chao PL; Jiang SY; Chang GG; Chang TC
Anticancer Res; 1997; 17(6D):4557-62. PubMed ID: 9494568
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro.
Simard J; Labrie C; Bélanger A; Gauthier S; Singh SM; Mérand Y; Labrie F
Int J Cancer; 1997 Sep; 73(1):104-12. PubMed ID: 9334816
[TBL] [Abstract][Full Text] [Related]
13. Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells.
Liu J; Li J; Sidell N
Cancer Chemother Pharmacol; 2007 Feb; 59(2):217-25. PubMed ID: 16738884
[TBL] [Abstract][Full Text] [Related]
14. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
15. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
16. Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer.
Sampath D; Winneker RC; Zhang Z
Endocrinology; 2001 Jun; 142(6):2540-8. PubMed ID: 11356703
[TBL] [Abstract][Full Text] [Related]
17. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
[TBL] [Abstract][Full Text] [Related]
18. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
Chalbos D; Philips A; Galtier F; Rochefort H
Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
[TBL] [Abstract][Full Text] [Related]
19. Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells.
de Cupis A; Noonan D; Pirani P; Ferrera A; Clerico L; Favoni RE
Br J Pharmacol; 1995 Nov; 116(5):2391-400. PubMed ID: 8581274
[TBL] [Abstract][Full Text] [Related]
20. C-myc overexpression, c-mil, c-myb expression in a breast tumor cell line. Effects of estrogen and antiestrogen.
Collyn-d'Hooghe M; Vandewalle B; Hornez L; Lantoine D; Revillion F; Lefebvre J; Kerckaert JP
Anticancer Res; 1991; 11(6):2175-9. PubMed ID: 1776859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
